These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9089706)

  • 21. Biotinylated iodo-polylysine for pretargeted radiation delivery.
    del Rosario RB; Wahl RL
    J Nucl Med; 1993 Jul; 34(7):1147-51. PubMed ID: 8315493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin.
    Rosebrough SF
    Nucl Med Biol; 1993 Jul; 20(5):663-8. PubMed ID: 8358353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient synthesis of a fluorine-18 labeled biotin derivative.
    Claesener M; Breyholz HJ; Hermann S; Faust A; Wagner S; Schober O; Schäfers M; Kopka K
    Nucl Med Biol; 2012 Nov; 39(8):1189-94. PubMed ID: 22998841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking [211At]astatide accumulation in normal tissues: preliminary evaluation of seven potential compounds.
    Larsen RH; Slade S; Zalutsky MR
    Nucl Med Biol; 1998 May; 25(4):351-7. PubMed ID: 9639296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
    Goodwin DA; Meares CF; Osen M
    J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a biotinylated somatostatin analog as a receptor probe.
    Schonbrunn A; Lee AB; Brown PJ
    Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioiodinated and astatinated NHC rhodium complexes: synthesis.
    Rajerison H; Guérard F; Mougin-Degraef M; Bourgeois M; Da Silva I; Chérel M; Barbet J; Faivre-Chauvet A; Gestin JF
    Nucl Med Biol; 2014 May; 41 Suppl():e23-9. PubMed ID: 24661351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
    Hashmi M; Rosebrough SF
    Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, purification, and in vitro stability of 211At- and 125I-labeled amidobisphosphonates.
    Murud KM; Larsen RH; Hoff P; Zalutsky MR
    Nucl Med Biol; 1999 May; 26(4):397-403. PubMed ID: 10382843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotin radioligand assay with an 125I-labeled biotin derivative, avidin, and avidin double-antibody reagents.
    Livaniou E; Evangelatos GP; Ithakissios DS
    Clin Chem; 1987 Nov; 33(11):1983-8. PubMed ID: 3499999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
    Garg PK; Harrison CL; Zalutsky MR
    Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma stability and pharmacokinetics of radiolabeled deferoxamine-biotin derivatives.
    Rosebrough SF
    J Pharmacol Exp Ther; 1993 Apr; 265(1):408-15. PubMed ID: 8474023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry.
    Orlova A; Höglund J; Lubberink M; Lebeda O; Gedda L; Lundqvist H; Tolmachev V; Sundin A
    Cancer Biother Radiopharm; 2002 Aug; 17(4):385-96. PubMed ID: 12396703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: potential peptide radiotherapeutics for somatostatin receptor-positive cancers.
    Vaidyanathan G; Boskovitz A; Shankar S; Zalutsky MR
    Peptides; 2004 Dec; 25(12):2087-97. PubMed ID: 15572196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin.
    Kassis AI; Jones PL; Matalka KZ; Adelstein SJ
    J Nucl Med; 1996 Feb; 37(2):343-52. PubMed ID: 8667075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the in vivo stability of different kinds of 211At-labeled particles].
    Wunderlich G; Fischer S; Franke WG; Dreyer R
    Radiobiol Radiother (Berl); 1988; 29(2):212-4. PubMed ID: 3399660
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation, characterization, and biological evaluation of a streptavidin-chimeric t84.66 conjugate for antibody pretargeting.
    Jia F; Shelton TD; Lewis MR
    Cancer Biother Radiopharm; 2007 Oct; 22(5):654-64. PubMed ID: 17979568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody.
    Yao Z; Garmestani K; Wong KJ; Park LS; Dadachova E; Yordanov A; Waldmann TA; Eckelman WC; Paik CH; Carrasquillo JA
    J Nucl Med; 2001 Oct; 42(10):1538-44. PubMed ID: 11585870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiolabeled biotinyl peptides as useful reagents for the study of proteolytic enzymes.
    Basak A; Boudreault A; Jean F; Chrétien M; Lazure C
    Anal Biochem; 1993 Mar; 209(2):306-14. PubMed ID: 8470802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.